Hypoglycemic Activity of Fruiting Body Extracts from Pycnoporus sanguineus (L.: Fr.) Murr. Mushroom

Tran Duc Tuong, Duong Xuan Chu, Bui Thi Minh Dieu

Abstract


Alpha-amylase and α-glucosidase are two main enzymes involved in carbohydrate metabolism. Inhibition of α-amylase and α-glucosidase can be said as an effective treatment for delaying the absorption of glucose after meals in people with diabetes mellitus. The objective of the present study is to provide an in vitro evidence for the potential hypoglycemic activity via inhibitory activity of the ethanolic and aqueous extracts from fruiting bodies of Pycnoporus sanguineus mushroom on α-amylase and α-glucosidase enzymes. Alpha-amylase and α-glucosidase inhibitory activities of aqueous and ethanolic extracts of P. sanguineus fruiting body were examined in a dose-response manner. Acarbose was used as a positive control. The results showed that the ethanolic extract of P. sanguineus possessed strong inhibitory activity on α-amylase and α-glucosidase with IC50 values of 97.08 and 92.60 μg/mL, respectively. The aqueous extract also exhibited moderate activity against α-amylase and α-glucosidase with IC50 values of 150.15 and 102.29 μg/mL, respectively. Which was significantly lower than that of acarbose with IC50 values of 85.12 and 68.36 μg/mL, respectively. The degree of α-amylase and α-glucosidase inhibition was correlated with the dose of inhibitors. From these results Pycnoporus sanguineus (Trametes sanguinea) possesses high potential in lowering blood glucose level, reduced insulin resistance and the risk of diabetic-related complications.

Keywords


Keywords: Alpha-amylase, alpha-glucosidase, diabetes mellitus, hypoglycemic activity, inhibitory activity, Pycnoporus sanguineus (Trametes sanguinea)

References


Ajith T. A., Janardhanan K. K., 2007. Indian medicinal mushrooms as a source of antioxidant and antitumor agents. Journal of Clinical Biochemistry and Nutrition, 40: 157–162.

Apostolidis E., Lee C. M., 2010. In vitro potential of Ascophyllum nodosum phenolic antioxidant-mediated α-glucosidase and α-amylase inhibition. Journal of Food Science, 75(3): 97–102.

Boa E., 2004. Wild Edible Fungi. A Global Overview of Their Use and Importance to People. Non-wood Forest Products Series no. 17. FAO, Rome, 147 pp.

Etxeberria U., De la Garza A. L., Campión J., Martínez J. A., Milagro F. I., 2012. Antidiabetic effects of natural plant extracts via inhibition of carbohydrate hydrolysis enzymes with emphasis on pancreatic alpha-amylase. Expert Opinion on Therapeutic Targets, 16(3): 269–297.

Geetika P., Krishna J. S., Babasaheb S., Rajashekar P. R., Sibi G., 2013. In vitro α-amylase and α-glucosidase inhibitor activities of Abutilon indicum leaves. Asian Journal of Pharmaceutical and Clinical Research, 6(5): 22–24.

Genuth S., Alberti K. G., Bennett P., Buse J., Defronzo R., Kahn R., Zimmet P., 2003. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care, 26(11): 3160–3167.

Gyemant G., Kandra L., Nagy V., Somsak L., 2003. Inhibition of human salivary α-amylase by Glucopyranosylidene-spiro-thiohydantoin. Biochemical and Biophysical Research Communications, 312: 334–339.

Hanh T. T. H., Chau N. M., Tram L. H., Luyen N. T., Binh P. T., Minh C. V., Nam N. H., Dat N. T., 2014. Inhibitors of α-glucosidase and α-amylase from Cyperus rotundus. Journal Pharmaceutical Biology, 52(1): 74–77.

Harborne J. B., 1973. Phytochemical Methods. Chapman and Hall Ltd., London: UK, pp. 49–188.

Kim J. S., Hyun T. K., Kim M. J., 2011. The inhibitory effects of ethanol extracts from sorghum, foxtail millet and proso millet on α-glucosidase and α-amylase activities. Food Chemistry, 124(4): 1647–1651.

Kusano R., Ogawa S., Matsuo Y., Tanaka T., Yazaki Y., Kouno I., 2011. Alpha-amylase and lipase inhibitory activity and structural characterization of acacia bark proanthocyanidins. Journal of Natural Products, 74(2): 119–128.

Kwon Y. -I., Apostolidis E., Shetty K., 2007. Evaluation of pepper (Capsicum annuum) for management of diabetes and hypertension. Journal of Food Biochemistry, 31(3): 370–385.

Kwon Y. -I., Apostolidis E., Shetty K., 2008. In vitro studies of Eggplant (Solanum melongena) phenolics as inhibitors of key enzymes relevant for type 2 diabetes and hypertension. Bioresource Technology, 99: 2981–2988.

Maggi S., Noale M., Pilotto A., Tiengo A., Cavallo Perin P., Crepaldi G., 2013. The Metabolic Study: Multidimensional assessment of health and functional status in older patients with type 2 diabetes taking oral antidiabetic treatment. Diabetes and Metabolism, 39(3): 236–243.

Malviya N., Jain S., Malviya S., 2010. Antidiabetic potential of medicinal plants. Acta Poloniae Pharmaceutica, 67(2): 113–118.

Matsui T., Ogunwande I. A., Abesundara K. J. M., Matsumoto K., 2006. Anti-hyperglycemic potential of natural products. Mini-Reviews in Medicinal Chemistry, 6(3): 349–356.

Ng K., Gu C., Zhang H., Putri C. Y., 2015. Evaluation of alpha-amylase and alpha-glucosidase inhibitory activity of flavonoids. International Journal of Food and Nutritional Science, 2(2): 174–179.

Njoku O. V., Obi C., 2009. Phytochemical constituents of some selected medicinal plants. African Journal of Pure and Applied Chemistry, 3(11): 228–233.

Ogunwande I. A., Matsui T., Fujise T., Matsumoto K., 2007. Alpha-glucosidase inhibitory profile of Nigerian medicinal plants in immobilized assay system. Food Science and Technology Research, 13(2): 169–172.

Okada S., 2011. Effects of lifestyle education on type 2 diabetes with an emphasis on a traditional Japanese diet. Diabetes Management, 1(6): 571–574.

Ortiz M. I., Ponce-Monter H. A., Fernández-Martínez E., Macías A., Rangel-Flores E., Izquierdo-Vega J. A., Sánchez-Gutiérrez M., 2010. Pharmacological Interaction between Gabapentin and Glibenclamide in the Formalin Test in the Diabetic Rat. Proceedings of the Western Pharmacology Society, 53: 49–51.

Osadebe P. O., Omeje E. O., Uzor P. F., David E. K., Obiorah D. C., 2010. Seasonal variation for the antidiabetic activity of Loranthus micranthus methanol extract. Asian Pacific Journal of Tropical Medicine, 3(3): 196–199.

Poongunran J., Perera H. K. I., Fernando W. I. T., Jayasinghe L., Sivakanesan R., 2015. Alpha-glucosidase and α-amylase inhibitory activities of nine Sri Lankan anti-diabetic plants. British Journal of Pharmaceutical Research, 7(5): 365–374.

Sales P. M., Souza P. M., Simeoni L. A., Magalh~aes P. O., Silveira D., 2012. Alpha-amylase Inhibitors: Are view of raw material and isolated compounds from plant source. Journal of Pharmacy & Pharmaceutical Sciences, 15(1): 141–183.

Sofowora A., 1993. Medicinal Plants and Traditional Medicine in Africa. Spectrum Books Ltd., Ibadan, Nigeria, pp. 191–289.

Su C. H., Lai M. N., Ng L. T., 2013. Inhibitory effects of medicinal mushrooms on alpha-amylase and alpha-glucosidase enzymes related to hyperglycemia. Food and Function, 4: 644–649.

Trease G. E., Evans W. C., 1989. Pharmacognosy, 11th Edition, Bailliere Tindall, London, pp. 45–50.

Wasser S. P., Weis A. L., 1999. Medicinal properties of substances occurring in higher basidiomycetes mushrooms: current perspective. International Journal of Medicinal Mushrooms, 1: 31–62.

WHO in Viet Nam, 2016. The growing burden of diabetes in Viet Nam. http://www.wpro.who.int/vietnam/mediacentre/features/feature_world_health_day_2016_vietnam/en/ [accessed: 05/08/2018].




DOI: https://doi.org/10.15625/2615-9023/v40n3.13146

Published by Vietnam Academy of Science and Technology